Avril Biopharma acquires USP-Ghana assets, launches African vaccine manufacturing technology push

.S. biotechnology company Avril Biopharma said on Monday it has acquired the assets of United States Pharmacopeia (USP) Ghana and established AfriVax GH Ltd to expand its contract development and manufacturing (CDMO) business in Africa
